The third year of the COVID-19 pandemic in the United States introduced vaccines for very young children and an updated booster, plus wider availability of an antiviral drug and at-home antigen tests. Here’s what we’ve learned since these achievements first made a splash.
Shots for the littlest kids
On June 18, the COVID-19 vaccine was recommended for children under 5, the last group in the United States waiting for the shots (SN Online: 6/17/22). The thumbs-up was supported by immunity and safety data and the clear-and-present health risks of COVID-19 for young kids.
Update: Many young children in the United States are still unvaccinated. Only 11 percent of those
→ Continue reading at Science News